NK cells work as the effector branch of the innate immune system and undergo activation in response to a reduction or complete abrogation of the self-human leukocyte antigen (HLA-I) alleles on tumor cells, with the release of granzyme and perforin alongside the production of IFN-gamma and TNF alpha [116]. This evidence concerns the gene IFNG and neoplasm.